Tobacco Cessation Field Study for Adults in Recovery - 1

Official Title: “Tobacco Cessation Clinical Field Study for Adults in Alcohol Abuse Recovery”

The project's aim is to provide a targeted, computer-administered intervention to facilitate tobacco cessation for clients in alcohol treatment. The main focus of "On the Air: A tobacco cessation program for adults in alcohol recovery" is to reduce tobacco use of clients in alcohol treatment. The program will be offered through inpatient, residential, and outpatient treatment programs to help those struggling with alcohol addiction to understand, reduce, and stop tobacco use. Clients will develop a personalized tobacco cessation plan relevant to their readiness to quit tobacco use. Based on the metaphor of a television network, this tobacco cessation program contains information on personal risks, peer stories, cravings and withdrawal, a variety of interactive activities and tools, and also motivational feedback and tips to assist in the quitting process. Phase I was a proof of concept phase, in which we delivered a prototype CD-ROM on tobacco cessation. Phase II will involve completing the development of a functional CD-ROM tool which will be subjected to a clinical field trial with a group of adults (n=196) in treatment facilities for alcohol recovery. The clinical field study will involve finalizing the content, interface, and interactive features of the CD-ROM. We will also gather satisfaction data from both clients and counselors in the various treatment facilities.

Intervention(s) in this Clinical Trial

• Behavioral: Tobacco Use Disorder

Primary Measures

• Smoking Behavior
• Smoking Cessation
• Substance Abuse

Inclusion Criteria:

• Carry a primary DSM-IV diagnosis of alcohol abuse or dependence
• Smoke at least one cigarette a day
• Be willing to sign informed consent and undergo initial assessment and follow-up
• Be willing to provide at least one collateral contact and collateral contact information

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Lead Investigator: National Institute on Drug Abuse (NIDA) NIH

Overall Clinical Trial Officials and Contacts

Stephen F Butler, Ph.D. Principal Investigator Inflexxion, Inc.  

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00109460

Study ID Number: NIDA-80460-1

ClinicalTrials.gov Identifier: NCT00109460

Health Authority: United States: Federal Government